Financhill
Back

Opthea Quote, Financials, Valuation and Earnings

Opthea Price Quote

$3.35
+0.01 (+3.72%)
(Updated: December 21, 2024 at 5:40 AM ET)

Opthea Key Stats

Sell
32
Opthea (OPT) is a Sell

Day range:
$3.23 - $3.53
52-week range:
$1.79 - $5.45
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2,137.37
P/B ratio:
0%

Volume:
15.1K
Avg. volume:
23.3K
1-year change:
24.17%
Market cap:
$514M
Revenue:
$124.7K
EPS:
$-2.76

How Much Does Opthea Make?

Data Unavailable

Is Opthea Growing As A Company?

Data Unavailable

Opthea Stock Price Performance

  • Did Opthea Stock Go Up Last Month?
    Opthea share price went up by 1.83% last month
  • Did OPT's Share Price Rise Over The Last Year?
    OPT share price rose by 24.17% over the past 1 year

What Is Opthea 52-Week High & Low?

  • What Is Opthea’s 52-Week High Share Price?
    Opthea has traded as high as $5.45 over the past 52 weeks
  • What Is Opthea’s 52-Week Low Share Price?
    Opthea has traded as low as $1.79 over the past 52 weeks

Opthea Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Opthea?

Data Unavailable

Is Opthea Cash Flow Positive?

Data Unavailable

Opthea Return On Invested Capital

Data Unavailable

Opthea Earnings Date & Stock Price

  • What Is Opthea's Stock Price Today?
    A single share of OPT can be purchased today for 3.34
  • What Is Opthea’s Stock Symbol?
    Opthea trades on the nasdaq under the ticker symbol: OPT
  • When Is Opthea’s Next Earnings Date?
    The next quarterly earnings date for Opthea is scheduled on August 29, 2025
  • When Is OPT's next ex-dividend date?
    Opthea's next ex-dividend date is December 22, 2024
  • How To Buy Opthea Stock?
    You can buy Opthea shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Opthea Competitors

  • Who Are Opthea's Competitors?
    Below is a list of companies who compete with Opthea or are related in some way:
    • Alterity Therapeutics Ltd (ATHE)
    • Immutep Ltd (IMMP)
    • Immuron Ltd (IMRN)
    • Kazia Therapeutics Ltd (KZIA)
    • Mesoblast Ltd (MESO)

Opthea Dividend Yield

Data Unavailable

Opthea Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 12.17
Upside from Last Price: 264.26%

Major Shareholders

Data Unavailable